Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;75(2):483-484.
doi: 10.1016/j.jhep.2021.05.009. Epub 2021 May 28.

High acceptance rate of COVID-19 vaccination in liver transplant recipients

Edoardo G Giannini  1 , Simona Marenco  2
Affiliations
Comment

High acceptance rate of COVID-19 vaccination in liver transplant recipients

Edoardo G Giannini et al. J Hepatol. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
Flow of liver transplant patients who were offered vaccination against COVID-19.
See this image and copyright information in PMC

Comment on

References

    1. Cornberg M., Buti M., Eberhardt C.S., Grossi P.A., Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021 Apr;74(4):944–951. doi: 10.1016/j.jhep.2021.01.032. - DOI - PMC - PubMed
    1. Webb G.J., Moon A.M., Barnes E., Barritt A.S., Marjot T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):643–644. doi: 10.1016/S2468-1253(20)30125-4. - DOI - PMC - PubMed
    1. Webb G.J., Moon A.M., Barnes E., Barritt A.S., 4th, Marjot T. Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. J Hepatol. 2021 Feb 5 doi: 10.1016/j.jhep.2021.01.036. S0168-8278(21)00085-4. - DOI - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021 Feb 4;384(5):403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed

Substances